cotoretigene toliparvovec

Biogen gene therapy for rare eye disease falls short in key clinical trial
MedCity News
Sun, 05/16/21 - 11:26 pm
Biogen
gene therapy
clinical trials
X-linked retinitis pigmentosa
cotoretigene toliparvovec